Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

410
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
410
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

79
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
79
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revue medicale suisse·2026
Same author

[Alcohol-associated hepatitis : 2025 update for the clinician].

Revue medicale suisse·2026
Same author

[ACEIs versus ARBs, how to choose?]

Revue medicale suisse·2026
Same author

[Menopause and cardiovascular risk : a window of opportunity for women's health].

Revue medicale suisse·2026
Same author

[Physical exercise in patients at cardiovascular risk : some practical considerations].

Revue medicale suisse·2026
Same author

Unmasking of Normocalcemic Primary Hyperparathyroidism After Sodium-Glucose Cotransporter-2 Inhibitor Initiation.

European journal of case reports in internal medicine·2025

Related Experiment Video

Updated: Feb 27, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

6.0K

[Direct oral anticoagulants : some practical considerations].

Stéphanie Bornet1, Christodoulos Dolapsakis1, Pierre-Auguste Petignat1

  • 1Service de médecine interne, Hôpital du Valais, Centre hospitalier du Valais romand, Hôpital de Sion, Av. du Grand-Champsec 80, 1950 Sion.

Revue Medicale Suisse
|July 5, 2017
PubMed
Summary

Direct oral anticoagulants (DOACs) offer improved safety and convenience over traditional anticoagulants like warfarin. However, careful consideration of specific clinical situations is still necessary for optimal use.

More Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.4K
Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

9.0K

Related Experiment Videos

Last Updated: Feb 27, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

6.0K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.4K
Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

9.0K

Area of Science:

  • Pharmacology
  • Cardiology
  • Internal Medicine

Background:

  • Thromboembolic event prevention traditionally relied on vitamin K antagonists (AVK) and heparins.
  • Direct oral anticoagulants (DOACs) have emerged since 2009, transforming anticoagulation management.
  • DOACs offer advantages such as a better safety profile and no need for routine monitoring.

Purpose of the Study:

  • To review practical considerations for using direct oral anticoagulants (DOACs).
  • To discuss specific clinical situations requiring careful DOAC management in hospital and ambulatory settings.

Main Methods:

  • Literature review of direct oral anticoagulants (DOACs).
  • Analysis of clinical practice guidelines and evidence regarding DOAC use.
  • Synthesis of practical considerations for managing anticoagulation.

Main Results:

  • DOACs represent a significant advancement in anticoagulation therapy.
  • Key advantages include enhanced safety and simplified management without routine monitoring.
  • Specific clinical scenarios necessitate careful application of DOACs.

Conclusions:

  • Direct oral anticoagulants (DOACs) have revolutionized thromboembolic event prevention.
  • Understanding specific clinical contexts is crucial for safe and effective DOAC therapy.
  • This review provides guidance for managing DOACs in diverse healthcare settings.